Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed1
Recruiting1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07220993Phase 1Recruiting
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2026-05-12
NCT03690011Phase 1Active Not Recruiting
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2021-08-02
NCT04345601Phase 1/2Completed
Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
Acute Respiratory Distress SyndromeCOVID-19Sars-CoV2
PrincipalinvestigatorStart date: 2021-02-12

Research Network

Collaboration Network

13 collaborators·12 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Helen Heslop, MD

Baylor College of Medicine

Moderately Similar
17 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV-2

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+1 more
Collaborated on 1 trial
Similarity Score34%

Rayne Rouce, MD

Baylor College of Medicine

Moderately Similar
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+1 more
Collaborated on 1 trial
Similarity Score34%

Rayne Rouce, MD

Pediatrics, Baylor College of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma

Worked with same sponsors:

Baylor College of MedicineCancer Prevention Research Institute of Texas+3 more
Collaborated on 1 trial
Similarity Score34%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19SARS-CoV-2
Similarity Score10%

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
15 trials

Shared therapeutic areas:

SARS-CoV-2COVID-19
Similarity Score10%

Mike Royal, MD

Sorrento Therapeutics, Inc.

Related
19 trials

Shared therapeutic areas:

COVID-19Respiratory Distress Syndrome, Acute
Similarity Score10%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score5%

Matthieu Jabaudon

University Hospital, Clermont-Ferrand

Related
8 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Acute
Similarity Score5%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score5%

Mohamed mamdouh Elsayed, MD

Lecturer

Related
11 trials

Shared therapeutic areas:

COVID-19
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07220993Phase 1PrincipalInvestigator

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
Recruiting
NCT03690011Phase 1PrincipalInvestigator

Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells

T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-non-Hodgkin Lymphoma
Active Not Recruiting
NCT04345601Phase 1/2PrincipalInvestigator

Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)

Acute Respiratory Distress SyndromeCOVID-19Sars-CoV2
Completed

All 3 trials loaded